The Scientist

» virology and disease/medicine

Most Recent

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Speaking of Science: 2016

Speaking of Science: 2016

By | December 19, 2016

Selected quotes from an eventful year

0 Comments

image: Phages Carry Antibiotic Resistance Genes

Phages Carry Antibiotic Resistance Genes

By | December 8, 2016

Researchers find evidence of antibiotic resistance genes in the DNA of viruses that infect bacteria.

1 Comment

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: Zika-Associated Microcephaly Can Present After Birth

Zika-Associated Microcephaly Can Present After Birth

By | November 23, 2016

Researchers report on more than a dozen cases in which babies who showed signs of in-utero infection but were born without symptoms of congenital Zika syndrome went on to develop brain abnormalities. 

1 Comment

image: More Success Fixing Sickle Cell Gene with CRISPR

More Success Fixing Sickle Cell Gene with CRISPR

By | November 9, 2016

Researchers say they have sufficient in vitro and animal data to apply for human testing.

0 Comments

Family members with a certain gene variant had unnecessary interventions, highlighting the potential hazards of precision medicine.

2 Comments

image: Zika Update

Zika Update

By | October 24, 2016

Virus’s effect on RNA methylation; identifying brain cells targeted by Zika; virus found in vaginal secretions for two weeks after infection; updated CDC recommendations for Miami

0 Comments

image: Culprit for Antibody Blockade Identified

Culprit for Antibody Blockade Identified

By | October 21, 2016

Type I interferon organizes several immune mechanisms to suppress B cell responses to a chronic viral infection.

0 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Athletes’ Microbiomes Differ from Nonathletes
  3. Stomach Cells Change Identity to Drive Precancerous State
  4. Mutation Linked to Longer Life Span in Men
AAAS